News & Events
News
An aggressive childhood cancer case opens new avenues for advanced cell therapies
A positive response to therapy in a paediatric patient with a renal rhabdoid tumour has enabled researchers to identify immune cells with anti-tumour activity in this rare cancer.
Interviews
Manel González-Piñero
Headof Innovation at CREB UPC and XarTEC SALUT
"Our main objectives are to develop a technologies map of the members of XarTEC SALUT and to find the most effective ways to support them."
The Research Centre for Biomedical Engineering (CREB) at the UPC, an institution affiliated with the Institut de Recerca Sant Joan de Déu (IRSJD), received top funding in 2020 from the European Regional Development Fund (ERDF), under the management of the Government of Catalonia, to create and coordinate XarTEC SALUT, Catalonia's first health technologies innovation and valorisation network.Agenda
Defensa tesi doctoral: Berta Estévez Arias
"'Precision medicine for rare neuromuscular diseases: clinical, genetic and pathophysiological studies"
Defensa tesi doctoral: Laura Carrera García
"Atrofia muscular espinal Tipo 2: historia natural e impacto de las nuevas terapias"
Communications office
Marta Rodríguez i Natalia Giles
marta.rodriguezt(ELIMINAR)@sjd.es & natalia.giles(ELIMINAR)@sjd.es
936009751 Ext. 77858 - 81048